本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

C4 Therapeutics, Inc.

2.72
+0.05001.87%
盘后2.740.0200+0.74%16:20 EDT
成交量:141.22万
成交额:389.68万
市值:1.94亿
市盈率:-1.72
高:2.85
开:2.71
低:2.64
收:2.67
52周最高:7.22
52周最低:1.09
股本:7,117.08万
流通股本:5,002.98万
量比:1.33
换手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-1.5822
每股收益(LYR):-1.5181
净资产收益率:-52.99%
总资产收益率:-22.80%
市净率:1.11
市盈率(LYR):-1.79

数据加载中...

公司资料

公司名字:
C4 Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2015
员工人数:
110
公司地址:
490 Arsenal Way,Suite120,Watertown,Massachusetts,United States
邮编:
02472
电话:
传真:
- -
简介:
C4 Therapeutics, Inc.于2015年10月7日在特拉华州注册成立。该公司是一家生物制药公司,致力于利用人体对蛋白质水平的自然调节作用,开发新的治疗性候选药物,以靶向和破坏引起疾病的蛋白质来治疗癌症,神经退行性疾病和其他疾病。

董事

名称
职位
Andrew Hirsch
Director, President and Chief Executive Officer
Marc A. Cohen
Co-Founder, Executive Chairman, Director
Alain J. Cohen
Director
Bruce Downey
Director
Elena Prokupets
Director
Kenneth C. Anderson
Director
Malcolm Salter
Director

股东

名称
职位
Andrew Hirsch
Director, President and Chief Executive Officer
William McKee
Chief Financial Officer
Adam Crystal
Chief Medical Officer
Jolie M. Siegel
Chief Legal Officer
Marc A. Cohen
Co-Founder, Executive Chairman, Director
Stewart Fisher
Chief Scientific Officer